Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Iovanace Biotherapeutics (IOVA) Has Strong Cash Cushion Even as CEO Exit Adds to Uncertainties - Mizuho
May 19, 2021 12:42 PM EDTMizuho Securities analyst Mara Goldstein weighed in on Iovanace Biotherapeutics (NASDAQ: IOVA) after the company announced that Maria Fardis, Ph.D. will resign as President and CEO of the company following today's regulatory setback.
"The commercial potential for lifileucel remains but the question... More
Iovance Biotherapeutics (IOVA) Halted on LUDP
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
Iovance Biotherapeutics (IOVA) CEO Resigns
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) disclosed:
On May 18, 2021, Maria Fardis, Ph.D., the Chief Executive Officer (CEO) of Iovance Biotherapeutics, Inc. (the Company), notified the Company that she will be resigning as President, CEO and a director of the Company to pursue other opportunities. The... More
